摘要
目的 观察阿替洛尔对老年冠心病人心率变异性( HRV) 的影响,探讨其临床意义。 方法 将86例老年冠心病人分为阿替洛尔组和对照组。阿替洛尔组在硝酸酯类扩冠药治疗基础上,加服阿替洛尔6-25 ~12-5 m g ,每日1 ~2 次,用24h Holter 资料对2 组的HRV 进行分析对比。 结果 阿替洛尔组HRV 参数中反映交感神经和迷走神经双重活性的SDNN(121-97 ±26-20) ms 、SDANN(107-77 ±25-90) ms 、SDNNindex(50-13 ±18-01) ms 及LF(398-81 ±281-12) ms2·Hz- 1较对照组有显著提高( P< 0-05) 。 结论 阿替洛尔对HRV 的影响主要是通过改善交感神经与迷走神经的失衡而实现的。
The aim of this study was to observe the influence of atenolol on heart rate variability (HRV)in elderly patients with coronary heart disease(CHD)and discuss its clinical significance. Methods 86 patients aged 60~78 with CHD were divided alternatively into 2 groups:control group,43 cases using nitrates only,and atenolol group,43 cases taking atenolol 6 25~12 5mg qd or bid together with nitrates.HRV were observed by Holters ambulatory ECG in all patients of the 2 groups. Results In the atenolol group,the index of HRV reflecting both the sympathetic and parasympathetic activities as SDNN(121 97±26 20)ms,SDANN(107 77±25 90)ms,SDNN index (50 13±18 01)ms and LF(396 81±281 12)ms 2.Hz -1 are all higher than the control group significantly ( P <0 05).It means the atenolol do influence both sympathetic and parasympathetic activities. Conclusions Hence HRV influenced by atenolol in the elderly patients was performed by improving the imbalance between the sympathetic and parasympathetic activities,use of atenolol in the CHD patients will be beneficial to prevention the malignant arrhythmias.
出处
《实用老年医学》
CAS
1999年第5期246-247,共2页
Practical Geriatrics
关键词
阿替洛尔
冠心病
心率变异性
治疗
Atenolol Coronary heart disease Heart rate variability